Ben Boursi

4.5k citations

107 papers · 2.0k indexed · h-index 26

Impact in

Biological Psychiatry top 5%
- Tryptophan and brain disorders
Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Screening and Detection
- Cancer Immunotherapy and Biomarkers

Papers in ⓘ

Oncology 58
- Pancreatic and Hepatic Oncology Research 13
- Colorectal Cancer Treatments and Studies 13
- Colorectal Cancer Screening and Detection 12
- Cancer Immunotherapy and Biomarkers 10
Biological Psychiatry 3

Co-authors: Yu‐Xiao Yang (46 shared papers)Ronac Mamtani (49 shared papers)Kevin Haynes (26 shared papers)Ido Lurie (4 shared papers)Nadir Arber (4 shared papers)Bruce J. Giantonio (16 shared papers)Yochai Wolf (2 shared papers)Hanan Guzner‐Gur (4 shared papers)
Journals: Journal of Clinical Oncology (15 papers)European Journal of Cancer (9 papers)Gastroenterology (5 papers)Clinical Colorectal Cancer (4 papers)Pharmacoepidemiology and Drug Safety (4 papers)
Partner nations: Israel United States Australia

In The Last Decade

Ben Boursi

102 papers receiving 2.0k citations

Peers

Countries citing papers authored by Ben Boursi

Since Specialization

Citations

This map shows the geographic impact of Ben Boursi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Boursi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Boursi more than expected).

Fields of papers citing papers by Ben Boursi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Boursi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Boursi. The network helps show where Ben Boursi may publish in the future.

Co-authors

The 25 scholars most cited alongside Ben Boursi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ben Boursi Line = papers co-authored together Ben Boursi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Recurrent antibiotic exposure may promote cancer formation – Another step in understanding the role of the human microbiota? European Journal of Cancer ·Ben Boursi, Ronac Mamtani, Kevin Haynes, Yu‐Xiao Yang	2015	204
2	Antibiotic Exposure and the Risk for Depression, Anxiety, or Psychosis The Journal of Clinical Psychiatry ·Ido Lurie, Yu‐Xiao Yang, Kevin Haynes, Ronac Mamtani, Ben Boursi	2015	164
3	A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes Gastroenterology ·Ben Boursi, Brian S. Finkelman, Bruce J. Giantonio, Kevin Haynes, Anil K. Rustgi, Andrew D. Rhim, Ronac Mamtani, Yu‐Xiao Yang	2016	136
4	The effect of past antibiotic exposure on diabetes risk European Journal of Endocrinology ·Ben Boursi, Ronac Mamtani, Kevin Haynes, Yu‐Xiao Yang	2015	110
5	Role of the microbiota in response to and recovery from cancer therapy Nature reviews. Immunology ·Stephen J. Blake, Yochai Wolf, Ben Boursi, David J. Lynn	2023	76
6	Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants JAMA Oncology ·Milind Javle, Einat Shacham‐Shmueli, Lianchun Xiao, Gauri Varadhachary, Naama Halpern, David R. Fogelman, Ben Boursi, Syeda Uruba, Ofer Margalit, Robert A. Wolff, Talia Golan	2021	67
7	Impact of antibiotic exposure on the risk of colorectal cancer Pharmacoepidemiology and Drug Safety ·Ben Boursi, Kevin Haynes, Ronac Mamtani, Yu‐Xiao Yang	2015	65
8	Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib The Oncologist ·Daniel Keizman, Maya Gottfried, Maya Ish‐Shalom, Natalie Maimon, Avivit Peer, Avivit Neumann, Hans J. Hammers, Mario A. Eisenberger, Victoria J. Sinibaldi, Роберто Пили, Henry Hayat, Svetlana Kovel, Avishay Sella, Ben Boursi, Rony Weitzen, Wilmosh Mermershtain, Keren Rouvinov, Raanan Berger, Michael A. Carducci	2013	52
9	Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study PLoS Medicine ·Ronac Mamtani, James D. Lewis, Frank I. Scott, Tariq Ahmad, David S. Goldberg, Jashodeep Datta, Yu‐Xiao Yang, Ben Boursi	2016	51
10	Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case–Control Study Cancer Immunology Research ·Yael Eshet, Erez N. Baruch, Ronnie Shapira‐Frommer, Yael Steinberg‐Silman, Teodor Kuznetsov, Guy Ben‐Betzalel, Sameh Daher, Iris Gluck, Nethanel Asher, Sara Apter, Jacob Schachter, Jair Bar, Ben Boursi, Gal Markel	2018	46
11	Current and Future Clinical Strategies in Colon Cancer Prevention and the Emerging Role of Chemoprevention Current Pharmaceutical Design ·Ben Boursi, Nadir Arber	2007	46
12	Thyroid Dysfunction, Thyroid Hormone Replacement and Colorectal Cancer Risk JNCI Journal of the National Cancer Institute ·Ben Boursi, Kevin Haynes, Ronac Mamtani, Yu‐Xiao Yang	2015	46
13	Neutrophil‐to‐lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710 Cancer ·Eric Ojerholm, Andrew M. Smith, Wei‐Ting Hwang, Brian C. Baumann, Kai Tucker, Seth P. Lerner, Ronac Mamtani, Ben Boursi, John P. Christodouleas	2016	43
14	Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre‐COVID‐19 reports British Journal of Clinical Pharmacology ·Adam Goldman, David Bomze, Rachel Dankner, Hanoch Hod, Tomer Meirson, Ben Boursi, Elad Maor	2020	42
15	Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma European Journal of Cancer ·Daniel Keizman, Maya Ish‐Shalom, Роберто Пили, Hans J. Hammers, Mario A. Eisenberger, Victoria J. Sinibaldi, Ben Boursi, Natalie Maimon, Maya Gottfried, Henry Hayat, Avivit Peer, Svetlana Kovel, Avishay Sella, Raanan Berger, Michael A. Carducci	2012	42
16	Proton pump inhibitors on pancreatic cancer risk and survival Cancer Epidemiology ·Malcolm D. Kearns, Ben Boursi, Yu‐Xiao Yang	2017	42
17	Diagnostic and Prognostic Significance of Serum C-Reactive Protein Levels in Patients Admitted to the Department of Medicine The American Journal of the Medical Sciences ·Rom Keshet, Ben Boursi, Ramit Maoz, M. Shnell, Hanan Guzner‐Gur	2009	41
18	Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study Arthritis & Rheumatology ·Ronac Mamtani, Amy S. Clark, Frank I. Scott, Colleen Brensinger, Ben Boursi, Lang Chen, Fenglong Xie, Huifeng Yun, Mark T. Osterman, Jeffrey R. Curtis, James D. Lewis	2016	37
19	Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma JCO Oncology Practice ·Erin M. Bange, Abigail Doucette, Peter Gabriel, Florence Porterfield, James J Harrigan, Robin Wang, Andrzej P. Wojcieszynski, Ben Boursi, Bethany I. Mooney, Kim A. Reiss, Ronac Mamtani	2020	35
20	The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews European Journal of Cancer ·Ben Boursi, Tal Sella, Eliezer Liberman, Shiran Shapira, Maayan David, Diana Kazanov, Nadir Arber, Sarah Kraus	2013	33

About Ben Boursi

Ben Boursi is a scholar working on Oncology, Biological Psychiatry, Surgery, Cancer Research and Gastroenterology, having authored 107 papers that have together received 2.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (13 papers), Colorectal Cancer Treatments and Studies (13 papers), Colorectal Cancer Screening and Detection (12 papers), Cancer Immunotherapy and Biomarkers (10 papers), Genetic factors in colorectal cancer (9 papers), Colorectal and Anal Carcinomas (9 papers), Gut microbiota and health (9 papers) and Cancer, Lipids, and Metabolism (8 papers). The work is most often cited by research in Biological Psychiatry (106 citations), Oncology (886 citations), Cancer Research (293 citations), Gastroenterology (87 citations) and Molecular Biology (802 citations). Ben Boursi has collaborated with scholars based in Israel, United States and Australia. Frequent co-authors include Yu‐Xiao Yang, Ronac Mamtani, Kevin Haynes, Ido Lurie, Nadir Arber, Bruce J. Giantonio, Yochai Wolf, Hanan Guzner‐Gur, David J. Lynn and Stephen J. Blake. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Gastroenterology, Clinical Colorectal Cancer and Pharmacoepidemiology and Drug Safety.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact